Lv1
10 积分 2023-10-21 加入
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2小时前
待确认
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
2小时前
已完结
Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy
2个月前
已完结
Hidden risk of Microplastics in Milk Tea and Coffee: A Case Study from China's Freshly-Made Beverage Market
3个月前
已完结
Impact of Removal of Lymph Nodes on Survival in Stage I–III Gastric Signet-Ring Cell Cancer: The More, the Better?
3个月前
已完结
皖公网安备34019202002308
